3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Lymphoid
1
CNS
1
Conditions
Prostatic Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Lung Neoplasms
2
Leukemia, Myeloid, Acute
2
Carcinoma, Renal Cell
2
Brain Neoplasms
2
Urinary Bladder Neoplasms
1
Ureteral Neoplasms
1
Triple Negative Breast Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Rectal Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pancreatic Neuroendocrine Tumors (pNET)
1
Oropharyngeal Neoplasms
1
Non-Muscle Invasive Bladder Neoplasms
1
Neoplasms
1
Melanoma
1
Lymphoma, Mantle-Cell
1
Head and Neck Neoplasms
1
Carcinoma, Squamous Cell
1
Breast Neoplasms
1
Breast Carcinoma In Situ
1
Anus Neoplasms
1
Anatomic Stage II Breast Cancer AJCC v8
1
Anal Canal Carcinoma
1
Interventions
Cyclophosphamide
23
fludarabine
15
fludarabine phosphate
10
Methotrexate
10
blinatumomab
9
Whole-Body Irradiation
9
Vincristine
7
Specimen Handling
7
Dexamethasone
7
merphos
6
Tacrolimus
6
Mycophenolic Acid
6
Stem Cell Transplantation
5
Peripheral Blood Stem Cell Transplantation
5
Mesna
5
Mercaptopurine
5
Melphalan
5
Leukapheresis
5
Granulocyte Colony-Stimulating Factor
5
Filgrastim
5
Cytarabine
5
Cyclosporine
5
Biopsy
5
pegaspargase
4
Prednisone
4
Magnetic Resonance Spectroscopy
4
Etoposide
4
Calcium Dobesilate
4
Busulfan
4
prednylidene
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Precursor Cell Lymphoblastic Leukemia-Lymphoma
×
Watchful Waiting
×
30 days
×
Clear all
NCT05375617
2026-06-02
EPICkids
Columbia University
Recruiting
1,400 enrolled